Table of Contents Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025 1 Industry Overview of Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics 1.1 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Overview 1.1.1 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product Scope 1.1.2 Market Status and Outlook 1.2 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size and Analysis by Regions 1.2.1 North America 1.2.2 Europe 1.2.3 China 1.2.4 Rest of Asia Pacific 1.2.5 Central & South America 1.2.6 Middle East & Africa 1.3 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market by Type 1.3.1 Stimulants 1.3.2 Non-Stimulants 1.4 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market by End Users/Application 1.4.1 Specialty Clinics 1.4.2 Hospital Pharmacies 1.4.3 Retail Pharmacies 1.4.4 E-Commerce 2 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Competition Analysis by Players 2.1 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Value) by Players (2018 and 2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future 3 Company (Top Players) Profiles 3.1 Eli Lilly and Company 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (Value) (2014-2019) 3.1.5 Recent Developments 3.2 Novartis 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (Value) (2014-2019) 3.2.5 Recent Developments 3.3 Shire 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (Value) (2014-2019) 3.3.5 Recent Developments 3.4 Pfizer 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (Value) (2014-2019) 3.4.5 Recent Developments 3.5 GlaxoSmithKline 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (Value) (2014-2019) 3.5.5 Recent Developments 3.6 Mallinckrodt Pharmaceuticals 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (Value) (2014-2019) 3.6.5 Recent Developments 3.7 Hisamitsu Pharmaceutical 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (Value) (2014-2019) 3.7.5 Recent Developments 3.8 Impax Laboratories 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (Value) (2014-2019) 3.8.5 Recent Developments 3.9 Johnson ＆Johnson 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (Value) (2014-2019) 3.9.5 Recent Developments 3.10 UCB 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (Value) (2014-2019) 3.10.5 Recent Developments 3.11 Purdue Parma 4 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type and Application (2014-2019) 4.1 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Type (2014-2019) 4.2 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2014-2019) 4.3 Potential Application of Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics in Future 4.4 Top Consumer/End Users of Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics 5 North America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Development Status and Outlook 5.1 North America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2014-2019) 5.2 North America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size and Market Share by Players (2018 and 2019) 6 Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Development Status and Outlook 6.1 Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2014-2019) 6.2 Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size and Market Share by Players (2018 and 2019) 7 China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Development Status and Outlook 7.1 China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2014-2019) 7.2 China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size and Market Share by Players (2018 and 2019) 8 Rest of Asia Pacific Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Development Status and Outlook 8.1 Rest of Asia Pacific Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2014-2019) 8.2 Rest of Asia Pacific Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size and Market Share by Players (2018 and 2019) 9 Central & South America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Development Status and Outlook 9.1 Central & South America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2014-2019) 9.2 Central & South America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size and Market Share by Players (2018 and 2019) 10 Middle East & Africa Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Development Status and Outlook 10.1 Middle East & Africa Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (2014-2019) 10.2 Middle East & Africa Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size and Market Share by Players (2018 and 2019) 11 Market Forecast by Regions, Type and Application (2019-2025) 11.1 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Value) by Regions (2019-2025) 11.1.1 North America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue and Growth Rate (2019-2025) 11.1.2 Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue and Growth Rate (2019-2025) 11.1.3 China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue and Growth Rate (2019-2025) 11.1.4 Rest of Asia Pacific Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue and Growth Rate (2019-2025) 11.1.5 Central & South America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue and Growth Rate (2019-2025) 11.1.6 Middle East & Africa Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue and Growth Rate (2019-2025) 11.2 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Value) by Type (2019-2025) 11.3 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size by Application (2019-2025) 12 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Dynamics 12.1 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Opportunities 12.2 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Challenge and Risk 12.2.1 Competition from Opponents 12.2.2 Downside Risks of Economy 12.3 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Constraints and Threat 12.3.1 Threat from Substitute 12.3.2 Government Policy 12.3.3 Technology Risks 12.4 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Driving Force 12.4.1 Growing Demand from Emerging Markets 12.4.2 Potential Application 13 Market Effect Factors Analysis 13.1 Technology Progress/Risk 13.1.1 Substitutes 13.1.2 Technology Progress in Related Industry 13.2 Consumer Needs Trend/Customer Preference 13.3 External Environmental Change 13.3.1 Economic Fluctuations 13.3.2 Other Risk Factors 14 Research Finding/Conclusion 15 Appendix Methodology Analyst Introduction Data Source

List of Tables and Figures Figure Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product Scope Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) (2014-2019) Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Regions in 2018 Figure North America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Rest of Asia Pacific Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Central & South America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Middle East & Africa Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Type in 2018 Figure Stimulants Market Size (Million USD) and Growth Rate (2014-2019) Figure Non-Stimulants Market Size (Million USD) and Growth Rate (2014-2019) Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Share by Application in 2018 Table Key Downstream Customer in Specialty Clinics Figure Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) and Growth Rate in Specialty Clinics (2014-2019) Table Key Downstream Customer in Hospital Pharmacies Figure Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2014-2019) Table Key Downstream Customer in Retail Pharmacies Figure Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) and Growth Rate in Retail Pharmacies (2014-2019) Table Key Downstream Customer in E-Commerce Figure Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) and Growth Rate in E-Commerce (2014-2019) Table Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) by Players (2018 and 2019) Figure Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Players in 2018 Figure Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Players in 2019 Table Eli Lilly and Company Basic Information List Table Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business Revenue (Million USD) of Eli Lilly and Company (2014-2019) Figure Eli Lilly and Company Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business Revenue Market Share in 2018 Table Novartis Basic Information List Table Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business Revenue (Million USD) of Novartis (2014-2019) Figure Novartis Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business Revenue Market Share in 2018 Table Shire Basic Information List Table Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business Revenue (Million USD) of Shire (2014-2019) Figure Shire Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business Revenue Market Share in 2018 Table Pfizer Basic Information List Table Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business Revenue (Million USD) of Pfizer (2014-2019) Figure Pfizer Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business Revenue Market Share in 2018 Table GlaxoSmithKline Basic Information List Table Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business Revenue (Million USD) of GlaxoSmithKline (2014-2019) Figure GlaxoSmithKline Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business Revenue Market Share in 2018 Table Mallinckrodt Pharmaceuticals Basic Information List Table Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business Revenue (Million USD) of Mallinckrodt Pharmaceuticals (2014-2019) Figure Mallinckrodt Pharmaceuticals Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business Revenue Market Share in 2018 Table Hisamitsu Pharmaceutical Basic Information List Table Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business Revenue (Million USD) of Hisamitsu Pharmaceutical (2014-2019) Figure Hisamitsu Pharmaceutical Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business Revenue Market Share in 2018 Table Impax Laboratories Basic Information List Table Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business Revenue (Million USD) of Impax Laboratories (2014-2019) Figure Impax Laboratories Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business Revenue Market Share in 2018 Table Johnson ＆Johnson Basic Information List Table Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business Revenue (Million USD) of Johnson ＆Johnson (2014-2019) Figure Johnson ＆Johnson Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business Revenue Market Share in 20187 Table UCB Basic Information List Table Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business Revenue (Million USD) of UCB (2014-2019) Figure UCB Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Business Revenue Market Share in 2018 Table Purdue Parma Basic Information List Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) by Type (2014-2019) Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Type in 2014 Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Type in 2015 Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Type in 2016 Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Type in 2017 Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Type in 2018 Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Type in 2019 Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) by Application (2014-2019) Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) by Application in 2014 Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) by Application in 2015 Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) by Application in 2015 Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) by Application in 2017 Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) by Application in 2018 Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) by Application in 2019 Table Top Consumer/End Users of Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Figure North America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table North America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) by Players (2014-2019) Figure North America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Players in 2018 Figure North America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Players in 2019 Figure Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) by Players (2014-2019) Figure Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Players in 2018 Figure Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Players in 2019 Figure China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) by Players (2014-2019) Figure China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Players in 2018 Figure China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Players in 2019 Figure Rest of Asia Pacific Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Rest of Asia Pacific Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) by Players (2014-2019) Figure Rest of Asia Pacific Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Players in 2018 Figure Rest of Asia Pacific Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Players in 2019 Figure Central & South America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Central & South America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) by Players (2014-2019) Figure Central & South America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Players in 2018 Figure Central & South America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Players in 2019 Figure Middle East & Africa Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Middle East & Africa Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) by Players (2014-2019) Figure Middle East & Africa Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Players in 2018 Figure Middle East & Africa Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Players in 2019 Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) by Regions (2019-2025) Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) by Regions (2019-2025) Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Regions in 2019 Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Regions in 2025 Figure North America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Rest of Asia Pacific Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Central & South America Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Middle East & Africa Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) by Type (2019-2025) Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Type in 2019 Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Share by Type in 2025 Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) by Application (2019-2025) Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) by Application in 2019 Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (Million USD) by Application in 2025

Eli Lilly and Company Novartis Shire Pfizer GlaxoSmithKline Mallinckrodt Pharmaceuticals Hisamitsu Pharmaceutical Impax Laboratories Johnson ＆Johnson UCB Purdue Parma